Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


27.02.2017

1 Ann N Y Acad Sci
6 Indian Pediatr
2 J Virol
2 Lancet Infect Dis
1 Pediatr Infect Dis J
4 PLoS One
1 Proc Natl Acad Sci U S A
11 Vaccine
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann N Y Acad Sci

  1. CAWEIN A, Emini E, Watson M, Dailey J, et al
    Human capital gaps in vaccine development: an issue for global vaccine development and global health.
    Ann N Y Acad Sci. 2017 Feb 23. doi: 10.1111/nyas.13316.
    PubMed     Text format     Abstract available


    Indian Pediatr

  2. JOHN TJ, Gupta P
    Celebrating Indias Achievements Towards Polio Eradication.
    Indian Pediatr. 2016;53 Suppl 1:S1.
    PubMed     Text format    

  3. THACKER N, Yewale VN, Pathak A
    Global Polio Eradication,The Journey So Far.
    Indian Pediatr. 2016;53 Suppl 1:S61-S64.
    PubMed     Text format     Abstract available

  4. HALDAR P, Agrawal P
    India's Preparedness for Introduction of IPV and Switch from tOPV to bOPV.
    Indian Pediatr. 2016;53 Suppl 1:S44-S49.
    PubMed     Text format     Abstract available

  5. JOHN TJ
    India's Research Contributions Towards Polio Eradication (1965-2015).
    Indian Pediatr. 2016;53 Suppl 1:S38-S43.
    PubMed     Text format     Abstract available

  6. PATEL M, Menning L, Bhatnagar P
    Polio Eradication and Endgame Plan - Victory within Grasp.
    Indian Pediatr. 2016;53 Suppl 1:S28-S32.
    PubMed     Text format     Abstract available

  7. AHMAD M, Bahl S, Kunwar A
    Cross-sectional Serologic Assessment of Immunity to Poliovirus in Differential Risk Areas of India: India Seroprevalence Survey - 2014.
    Indian Pediatr. 2016;53 Suppl 1:S14-S19.
    PubMed     Text format     Abstract available


    J Virol

  8. HENSEL MT, Marshall JD, Dorwart MR, Heeke DS, et al
    Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reserv
    J Virol. 2017 Feb 22. pii: JVI.02257-16. doi: 10.1128/JVI.02257.
    PubMed     Text format     Abstract available

  9. GRANT CF, Carr BV, Kotecha A, van den Born E, et al
    The B cell response to foot-and-mouth disease virus in cattle following sequential vaccination with multiple serotypes.
    J Virol. 2017 Feb 22. pii: JVI.02157-16. doi: 10.1128/JVI.02157.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  10. SISSOKO MS, Healy SA, Katile A, Omaswa F, et al
    Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Lancet Infect Dis. 2017 Feb 16. pii: S1473-3099(17)30104.
    PubMed     Text format     Abstract available

  11. GREENWOOD B
    Progress with the PfSPZ Vaccine for malaria.
    Lancet Infect Dis. 2017 Feb 15. pii: S1473-3099(17)30105.
    PubMed     Text format    


    Pediatr Infect Dis J

  12. SEDERDAHL BK, Yi J, Jerris R, Gillespie SE, et al
    The Residual Vaccine-Preventable Burden of Rotavirus Disease.
    Pediatr Infect Dis J. 2017 Feb 15. doi: 10.1097/INF.0000000000001580.
    PubMed     Text format     Abstract available


    PLoS One

  13. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Text format     Abstract available

  14. DALGIC OO, Ozaltin OY, Ciccotelli WA, Erenay FS, et al
    Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.
    PLoS One. 2017;12:e0172261.
    PubMed     Text format     Abstract available

  15. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    PubMed     Text format     Abstract available

  16. SALIH DA, Pelle R, Mwacharo JM, Njahira MN, et al
    Genes encoding two Theileria parva antigens recognized by CD8+ T-cells exhibit sequence diversity in South Sudanese cattle populations but the majority of alleles are similar to the Muguga component of the live vaccine cocktail.
    PLoS One. 2017;12:e0171426.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. LYKE KE, Ishizuka AS, Berry AA, Chakravarty S, et al
    Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Proc Natl Acad Sci U S A. 2017 Feb 21. pii: 201615324.
    PubMed     Text format     Abstract available


    Vaccine

  18. LAVAN RP, King AI, Sutton DJ, Tunceli K, et al
    Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30195.
    PubMed     Text format     Abstract available

  19. BATRA SA, Shanthalingam S, Donofrio G, Haldorson GJ, et al
    Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine.
    Vaccine. 2017 Feb 19. pii: S0264-410X(17)30170.
    PubMed     Text format     Abstract available

  20. VAN AALST S, Ludwig IS, van Kooten PJ, van der Zee R, et al
    Dynamics of APC recruitment at the site of injection following injection of vaccine adjuvants.
    Vaccine. 2017 Feb 17. pii: S0264-410X(17)30168.
    PubMed     Text format     Abstract available

  21. KRISS JL, Frew PM, Cortes M, Malik FA, et al
    Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30086.
    PubMed     Text format     Abstract available

  22. WEILHAMMER D, Dunkle AD, Blanchette CD, Fischer NO, et al
    Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30167.
    PubMed     Text format     Abstract available

  23. CHEUNG K, Ho SM, Lam W
    Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: A large-scale cross-sectional study.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30164.
    PubMed     Text format     Abstract available

  24. NORRBY M, Vesikari T, Lindqvist L, Maeurer M, et al
    Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30120.
    PubMed     Text format     Abstract available

  25. MASLOW JN
    Vaccine development for emerging virulent infectious diseases.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30196.
    PubMed     Text format     Abstract available

  26. DE SILVA R, Dasanayake WM, Wickramasinhe GD, Karunatilake C, et al
    Sensitization to bovine serum albumin as a possible cause of allergic reactions to vaccines.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30173.
    PubMed     Text format     Abstract available

  27. PRADA JM, Metcalf CJ, Takahashi S, Lessler J, et al
    Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30172.
    PubMed     Text format     Abstract available

  28. MODOLO DG, Araldi RP, Mazzuchelli-de-Souza J, Pereira A, et al
    Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine.
    Vaccine. 2017 Feb 17. pii: S0264-410X(17)30171.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  29. Human rabies: 2016 updates and call for data.
    Wkly Epidemiol Rec. 2017;92:77-86.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: